| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |